BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 679979)

  • 21. [Cardiac output and central-hemodynamic parameter under bencyclan (author's transl)].
    Heidrich H; Paeprer H; Schneider B
    Z Kardiol; 1979 Jan; 68(1):53-6. PubMed ID: 419810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some effects of the trypanocidal drug isometamidium on encapsulation in bovine carrier erythrocytes.
    DeLoach JR; Wagner GG
    Biotechnol Appl Biochem; 1988 Oct; 10(5):447-53. PubMed ID: 3196446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bencyclan's effects "in vitro" on fibrinolysis (author's transl)].
    Bucci M; Faggiani L; Formichi R; Paoli L
    Quad Sclavo Diagn; 1977 Dec; 13(4):478-81. PubMed ID: 614608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin enhances the in vitro action of cytochalasin B on globular resistance and osmotic fragility of erythrocytes.
    Pacini N; Ferrari A; Menozzi M; Borziani F
    Neuro Endocrinol Lett; 2011; 32(3):292-300. PubMed ID: 21712781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of platelet aggregation in vivo i. Effect of bencyclan.
    Ambrus JL; Ambrus CM; Gastpar H; Sapvento PJ; Weber FJ; Thurber LE
    J Med; 1976; 7(6):439-47. PubMed ID: 827596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of membrane stabilizing activity from honey. An in-vitro approach.
    Manukumar HM; Umesha S
    Acta Sci Pol Technol Aliment; 2015; 14(1):85-90. PubMed ID: 28068024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of imipramine on the osmotic resistance of erythrocytes].
    Förika M; Förika G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(1):39-43. PubMed ID: 653157
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells.
    Gastpar H; Ambrus J; Thurber LE
    J Med; 1977; 8(1):53-6. PubMed ID: 267156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Membrane stabilizing effect of medicinal substances used for the treatment of chronic venous insufficiency].
    Chaĭka LA; Khadzhaĭ IaI
    Farmakol Toksikol; 1977; 40(3):306-9. PubMed ID: 578500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmented osmotic hemolysis of human erythrocytes exposed to the galactosephilic lectin of Pseudomonas aeruginosa.
    Gilboa-Garber N; Blonder E
    Isr J Med Sci; 1979 Jun; 15(6):537-9. PubMed ID: 110727
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlation between changes of shape and of osmotic resistance of human erythrocytes induced by amphipathic drugs (author's transl)].
    Kanaho Y; Sato T; Fujii T
    Yakugaku Zasshi; 1979 Jan; 99(1):8-13. PubMed ID: 430349
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of copper on erythrocyte deformability: a possible mechanism of hemolysis in acute copper intoxication.
    Adams KF; Johnson G; Hornowski KE; Lineberger TH
    Biochim Biophys Acta; 1979 Jan; 550(2):279-87. PubMed ID: 758948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in erythrocytic osmotic resistance under the action of hydrogen sulfide baths in rats of different ages].
    Briukhanova LK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (1):66-9. PubMed ID: 636359
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of protoporphyrin on human erythrocyte membrane (author's transl)].
    Sato T; Kanaho Y; Fujii T; Riku J
    Yakugaku Zasshi; 1981 Dec; 101(12):1137-42. PubMed ID: 7338801
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of derivatives of hydroxypyruvaldehyde phenylosazone on bovine erythrocyte membrane. I. Influence on the osmotic fragility and morphology.
    Ikezawa H; Mizuno M; Nakabayashi T; Ogawa H; Shindo M; Matsunaga I
    Chem Pharm Bull (Tokyo); 1982 Mar; 30(3):959-65. PubMed ID: 7094172
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of anesthetics and heart treatment on deformability and osmotic fragility of red blood cells.
    de Bruijne AW; van Steveninck J
    Biochem Pharmacol; 1979; 28(2):177-82. PubMed ID: 426832
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis.
    Cruz Silva MM; Madeira VM; Almeida LM; Custódio JB
    Toxicol In Vitro; 2001 Dec; 15(6):615-22. PubMed ID: 11698160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased membrane fragility of mouse erythrocytes by small dose of methylmercury and its restoration by coadministered selenite.
    Yamamoto R; Suzuki T
    Tohoku J Exp Med; 1982 Jul; 137(3):297-303. PubMed ID: 7112551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Decrease of disaccharidase activity following application of bencyclan-hydrogenfumarate (author's transl)].
    Frisius H; Al-Abadi H; Heidrich H
    Klin Wochenschr; 1976 Sep; 54(18):895-7. PubMed ID: 966636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of polyoxyethylene chain length on erythrocyte hemolysis induced by poly[oxyethylene (n) nonylphenol] non-ionic surfactants.
    Galembeck E; Alonso A; Meirelles NC
    Chem Biol Interact; 1998 May; 113(2):91-103. PubMed ID: 9717511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.